Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 6, 2023Open Access

Secondary etiology linked to ~54-fold greater risk of poor prognosis in adult autoimmune hemolytic anemia.

View Full Paper
Ask AI
Bookmark
Share

Why the study?

The study was conducted to explore the clinical characteristics and prognostic factors of adult autoimmune hemolytic anemia to improve awareness and reduce misdiagnosis.

Design

Retrospective single-center study

Key result

The presence of secondary etiology (OR 54.306) and decreased hemoglobin levels were identified as independent risk factors for poor prognosis in adult autoimmune hemolytic anemia.

Authors

XXXiang XueCHChangbao HuangSNShinan Nie

Discussion

Loading...

Member takes

Overview

May guide prognosis assessment in adult AIHA; hypothesis-generating pending prospective validation.

Study Design

Type

Observational (n=41)

Multicenter

No

Structured PICO

P
Population
41 adult patients over 14 years old with newly diagnosed autoimmune hemolytic anemia, evaluated retrospectively to determine clinical characteristics and prognostic factors.
O
Outcome
Clinical characteristics and prognostic influencing factors

Main Result

Odds Ratio: 54.306 (95% CI 2.263–1303.371)

p-value: p=0.014

In adult patients with autoimmune hemolytic anemia, hemoglobin level and secondary etiology are independent risk factors for poor prognosis, and the disease presents with complex, non-specific symptoms leading to frequent misdiagnosis.

Limitations

  • Retrospective study at a single medical center
  • Limited sample size
  • Detection of specific types of autoantibodies was not feasible due to hospital testing constraints

Cite This Study

Xue et al. (2023) conducted an observational in Autoimmune hemolytic anemia (n=41). Secondary etiology vs. Primary etiology was evaluated on Poor prognosis (non-response to treatment, transfer, or death) (OR 54.306, 95% CI 2.263-1303.371, p=0.014). The presence of secondary etiology (OR 54.306) and decreased hemoglobin levels were identified as independent risk factors for poor prognosis in adult autoimmune hemolytic anemia.

synapsesocial.com/papers/6aa4bf8050d1b974a3f2d3afhttps://doi.org/10.21203/rs.3.rs-3396807/v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Real-world evidence from China: Clinical characteristics, treatment landscape and long-term outcomes in 566 autoimmune hemolytic anemia patients2025
  2. 2Autoimmune hemolytic anemia with an initially negative direct antiglobulin test: A diagnostic challenge2025
  3. 3Challenges in the diagnosis and management of autoimmune hemolytic anemia: A case-based approach. Experience from a tertiary care hospital in the Haryana region2024
  4. 4Novel insights from a large cohort: Elucidating incidence, risk factors, treatment, and prognostic predictors in autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation2026
  5. 5Red cell serological characterization of autoimmune hemolytic anemia in systemic lupus erythematosus patients2024